Screener
Cullinan Therapeutics, Inc. CGEM Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Cullinan Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336717
FAQ
- What is Cullinan Therapeutics, Inc.'s total assets?
- Cullinan Therapeutics, Inc. (CGEM) reported total assets of $363.79M in Q2 2026.
- How has Cullinan Therapeutics, Inc.'s total assets changed year-over-year?
- Cullinan Therapeutics, Inc.'s total assets decreased by 30.1% year-over-year, from $520.33M to $363.79M.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s total assets?
- Over 5 years (2020 to 2025), Cullinan Therapeutics, Inc.'s total assets has grown at a 15.9% compound annual growth rate (CAGR), from $214.71M to $448.37M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Cullinan Therapeutics, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude